{"id":16295,"date":"2016-06-06T23:58:48","date_gmt":"2016-06-06T21:58:48","guid":{"rendered":"http:\/\/alcyon:7777\/transgene170914\/?p=16295"},"modified":"2025-11-12T16:37:22","modified_gmt":"2025-11-12T15:37:22","slug":"a-phase-3-randomized-open-label-study-comparing-pexa-vec-vaccinia-gm-csf-thymidine-kinase-deactivated-virus-followed-by-sorafenib-versus-sorafenib-in-patients-with-advanced-hepatocellular-carcino","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/a-phase-3-randomized-open-label-study-comparing-pexa-vec-vaccinia-gm-csf-thymidine-kinase-deactivated-virus-followed-by-sorafenib-versus-sorafenib-in-patients-with-advanced-hepatocellular-carcino\/","title":{"rendered":"A Phase 3 Randomized, Open-Label Study Comparing Pexa-Vec (Vaccinia GM-CSF \/ Thymidine Kinase-Deactivated Virus) Followed by Sorafenib Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC) Without Prior Systemic Therapy"},"content":{"rendered":"<p><a href=\"http:\/\/meetinglibrary.asco.org\/content\/122703?media=vm&amp;intcmp=AM15iPlanner-W eb-ViewPoster-122703\"><\/a><br \/>\nGhassan K. Abou-Alfa, et al.<br \/>\nASCO Annual Meeting 2016, June 3-7, 2016, Chicago Illinois<br \/>\nDownload the poster <a href=\"http:\/\/meetinglibrary.asco.org\/content\/122703?media=vm&amp;intcmp=AM15iPlanner-W eb-ViewPoster-122703\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>here<\/strong><\/a><br \/>\n<em>Poster Presentation<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ghassan K. Abou-Alfa, et al. ASCO Annual Meeting 2016, June 3-7, 2016, Chicago Illinois Download the poster here Poster Presentation<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[181,129,14,5],"tags":[],"class_list":["post-16295","post","type-post","status-publish","format-standard","hentry","category-other-fr","category-129","category-pexa-vec-fr","category-publication-fr","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"Ghassan K. Abou-Alfa, et al. ASCO Annual Meeting 2016, June 3-7, 2016, Chicago Illinois Download the poster here Poster Presentation","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/16295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=16295"}],"version-history":[{"count":1,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/16295\/revisions"}],"predecessor-version":[{"id":38804,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/16295\/revisions\/38804"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=16295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=16295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=16295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}